Says liquidity, capital position "remain excellent." Expects 2H23 earnings to represent slightly more than 50% of FY total. Expects Q3 earnings "slightly higher" than Q4. Sees FY23 CapEx $2.8B-$3B.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CVS: